I am a
Home I AM A Search Login

Pain and Placebo


[Term 2018-2022]

Chair: Luana Colloca (USA)
Vice Chair: Andrea Evers (Netherlands)
Past Chair/Treasurer: Damien Finniss (Australia)
Secretary: TBD

The SIG on Placebo aims to:

  • Gather all available scientific data on placebo in its various aspects and manifestations.
  • Define the subject of placebo in pain research.
  • Evaluate placebo and its effects in the treatment of pain.
  • Stimulate the international study of placebo and its phenomena as a possibly useful mechanism.


  • Colloca L, Barsky AJ. Placebo and nocebo effects. N Engl J Med. 2020 Feb; 382(6): 554–61.
  • Colloca L. The Placebo Effect in Pain Therapies. Annu Rev Pharmacol Toxicol. 2019 Jan 6;59:191-211.
  • Evers AW, Colloca L, Blease C, Annoni M, Atlas LY, Benedetti F, et al. Implications of placebo and nocebo effects for clinical practice: expert consensus. Psychother Psychosom. 2018; 87(4): 204–10.
  • Evers, A. W., Colloca, L., Blease, C., Gaab, J., Jensen, K. B., Atlas, L. Y., ... & Bussemaker, J. What Should Clinicians Tell Patients about Placebo and Nocebo Effects? Practical Considerations Based on Expert Consensus. Psychotherapy and Psychosomatics, 1-8.
  • Matthias Zunhammer, Tamás Spisák, Tor D Wager, Ulrike Bingel, Placebo Imaging Consortium. Meta-analysis of neural systems underlying placebo analgesia from individual participant fMRI data. Nat Commun. 2021 Mar 2;12(1):1391.

Share this